Table 5 Comparison of the occurrence of safety end points in patients treated with and without mild therapeutic hypothermia
| Patients undergoing MTH procedure | Control group | p | |
|---|---|---|---|
| (n = 32) | (n = 33) | ||
| Definite stent thrombosis* | 0 (0%) | 0 (0%) | ns |
| Probable stent thrombosis* | 0 (0%) | 2 (7.4%) | ns |
| Pneumonia | 19 (59.4%) | 19 (57.6%) | ns |
| Positive blood culture | 12 (37.5%) | 11 (33.3%) | ns |
| Bleeding of any severity | 8 (25.0%) | 5 (15.2%) | ns |
| Red blood cell transfusion | 4 (12.5%) | 2 (6.1%) | ns |
| Rhythm and conductions disorders: | ns | ||
| Atrial fibrillation | 6 (18.8%) | 7 (21.2%) | |
| Ventricular tachycardia | 3 (9.4%) | 1 (3.0%) | ns |
| Clinically relevant bradycardia | 3 (9.4%) | 1 (3.0%) | ns |